Boundary Capital

Boundary Capital is a London-based venture capital firm focused on impact investing in early-stage companies that aim to improve lives and deliver strong commercial returns. Their investment strategy centers on technologies in life sciences, engineering, and data science that address critical global challenges such as healthcare, sustainability, and education. By aligning economic success with positive societal impact, Boundary Capital looks for businesses that offer innovative solutions to real-world problems. The firm typically invests in businesses from late seed to Series B stages, targeting returns of 3x within five to seven years. They place a strong emphasis on companies with proven economic potential and intellectual property advantages. Their portfolio includes high-growth companies like Glyconics, which is developing diagnostics for chronic lung diseases, and Echion, which focuses on fast-charging battery technology. Boundary's team combines extensive entrepreneurial and investment expertise. Led by Managing Partner Dan Somers, the firm supports portfolio companies with strategic guidance, leveraging both their financial investment and hands-on operational support.